Truths and lesser truths: an interpretation of clinical trials in glaucoma.
The objective of this article is to provide a selective review of risk inference from the recent clinical trials in glaucoma. It is not meant to serve as a comprehensive review of the findings from each of the studies but a discussion of some of the pertinent "sound bites" that have emerged from the studies with a focus on their scientific and practical validity.
Chauhan
Balwantray C
BC
Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada. bal@dal.ca
D001766:Blindness / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003315:Cornea / Q000473:pathology*; D018450:Disease Progression; D005901:Glaucoma / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008137:Longitudinal Studies; D012307:Risk Factors